Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Free Cash Flow (2021 - 2025)

Lucid Diagnostics' Free Cash Flow history spans 5 years, with the latest figure at -$12.6 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 24.74% year-over-year to -$12.6 million; the TTM value through Dec 2025 reached -$46.7 million, down 5.05%, while the annual FY2025 figure was -$46.7 million, 5.05% down from the prior year.
  • Free Cash Flow reached -$12.6 million in Q4 2025 per LUCD's latest filing, down from -$10.9 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$2.2 million in Q3 2021 to a low of -$13.5 million in Q2 2022.
  • Average Free Cash Flow over 5 years is -$8.8 million, with a median of -$10.1 million recorded in 2023.
  • The largest YoY upside for Free Cash Flow was 60.21% in 2022 against a maximum downside of 490.02% in 2022.
  • A 5-year view of Free Cash Flow shows it stood at -$10.7 million in 2021, then surged by 60.21% to -$4.3 million in 2022, then tumbled by 138.47% to -$10.2 million in 2023, then increased by 0.24% to -$10.1 million in 2024, then fell by 24.74% to -$12.6 million in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Free Cash Flow are -$12.6 million (Q4 2025), -$10.9 million (Q3 2025), and -$10.6 million (Q2 2025).